LeaderStat

Belkins
LeaderStat is a national recruiting and consulting firm dedicated to the healthcare industry. We place top performers in key roles on an interim, retained and contingency basis. Our consulting division assists clients in a variety of operational areas including clinical reimbursement, financial and operational analysis, ACO integration and alignment, survey readiness and many other areas critical to our client’s success.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

CORONAVIRUS VACCINE: JOHNSON & JOHNSON PLEDGES 100M DOSES TO U.S. FOR $10 EACH

Johnson & Johnson | August 06, 2020

news image

With leading COVID-19 vaccines in late-stage testing, companies have been inking supply deals with the U.S. government for a quick rollout if their programs succeed. Now, Johnson & Johnson is getting into the act. The pharma giant struck a deal to supply 100 million doses of its candidate, Ad26.COV2.S, if the shot is cleared for use by the FDA. The U.S. government is committing just over $1 billion under the agreement for a price per dose of about $10. That compares with a lower price-...

Read More

PHARMACY MARKET

YANGTZE RIVER PHARMACEUTICAL GROUP SELECTS TRACELINK PLATFORM FOR GLOBAL COMPLIANCE

Yangtze River Pharmaceutical, TraceLink | May 06, 2021

news image

TraceLink Inc., the leading digital network platform company, today announced that Yangtze River Pharmaceutical Group has selected TraceLink's global compliance solution to aid its plans for global growth. As the company gears up for international market expansion this year, Yangtze River Pharmaceutical Group (YRPG) will use TraceLink's multienterprise compliance applications and industry-leading digital supply network to comply with track and trace requirements in multiple markets, incl...

Read More

INSURERS TAKE AIM AT BIG PHARMA. THIS SMALL-CAP STOCK STANDS TO WIN.

Fool.com | January 30, 2020

news image

The premise of generic drugs was simple enough. Branded medicines protected by a patent tend to be overpriced, but the equivalent therapy made by other companies once a patent expires should lead to price-lowering competition. As it turns out, however, generic drugs have become overpriced as well. That's the stance the state of California has taken, anyway, with Governor Gavin Newsom announcing early this month the state is planning to launch its own prescription drug label. The Blue Cross B...

Read More

LANTERN PHARMA’S PROPRIETARY A.I. PLATFORM SURPASSES 450 MILLION DATA POINTS ACCELERATING ONCOLOGY DRUG DEVELOPMENT AND DRUG RESPONSE PREDICTION

Lantern Pharma | June 30, 2020

news image

Lantern Pharma, a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from its targeted oncology therapies, announced today that it surpassed the milestone of 450 million curated data points being utilized in its proprietary A.I. and machine learning-powered platform, RADR® (Response Algorithm for Drug Positioning and...

Read More

Johnson & Johnson | August 06, 2020

news image

CORONAVIRUS VACCINE: JOHNSON & JOHNSON PLEDGES 100M DOSES TO U.S. FOR $10 EACH

With leading COVID-19 vaccines in late-stage testing, companies have been inking supply deals with the U.S. government for a quick rollout if their programs succeed. Now, Johnson & Johnson is getting into the act. The pharma giant struck a deal to supply 100 million doses of its candidate, Ad26.COV2.S, if the shot is cleared for use by the FDA. The U.S. government is committing just over $1 billion under the agreement for a price per dose of about $10. That compares with a lower price-...

Read More

PHARMACY MARKET

Yangtze River Pharmaceutical, TraceLink | May 06, 2021

news image

YANGTZE RIVER PHARMACEUTICAL GROUP SELECTS TRACELINK PLATFORM FOR GLOBAL COMPLIANCE

TraceLink Inc., the leading digital network platform company, today announced that Yangtze River Pharmaceutical Group has selected TraceLink's global compliance solution to aid its plans for global growth. As the company gears up for international market expansion this year, Yangtze River Pharmaceutical Group (YRPG) will use TraceLink's multienterprise compliance applications and industry-leading digital supply network to comply with track and trace requirements in multiple markets, incl...

Read More

Fool.com | January 30, 2020

news image

INSURERS TAKE AIM AT BIG PHARMA. THIS SMALL-CAP STOCK STANDS TO WIN.

The premise of generic drugs was simple enough. Branded medicines protected by a patent tend to be overpriced, but the equivalent therapy made by other companies once a patent expires should lead to price-lowering competition. As it turns out, however, generic drugs have become overpriced as well. That's the stance the state of California has taken, anyway, with Governor Gavin Newsom announcing early this month the state is planning to launch its own prescription drug label. The Blue Cross B...

Read More

Lantern Pharma | June 30, 2020

news image

LANTERN PHARMA’S PROPRIETARY A.I. PLATFORM SURPASSES 450 MILLION DATA POINTS ACCELERATING ONCOLOGY DRUG DEVELOPMENT AND DRUG RESPONSE PREDICTION

Lantern Pharma, a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from its targeted oncology therapies, announced today that it surpassed the milestone of 450 million curated data points being utilized in its proprietary A.I. and machine learning-powered platform, RADR® (Response Algorithm for Drug Positioning and...

Read More